UNSPSC 51161563: Zafirlukast

This classification denotes an anti-asthmatic agent with the molecular formula C31H33N3O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XZ629S5L50, chemically known as ici 204,219 but generally known as zafirlukast, which bears US NIH Compound Identifier 5717. European Medicines Agency schedules Zafirlukast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00128MIG.

UNSPSC 51161563 Zafirlukast is a Commodity code naming a specific pharmaceutical product — an oral leukotriene-receptor antagonist used to treat asthma and allergic rhinitis. State and local governments procure this medication primarily through public health agencies, school districts (for student health programs), correctional facilities, and municipal or county health departments serving uninsured or low-income populations. The drug is typically bought as a brand-name or generic tablet formulation through group purchasing organizations, state Medicaid programs, or direct vendor contracts negotiated at the state or local level. School districts and detention facilities often source it through standing supply agreements or cooperative purchasing vehicles that allow individual sites to order against statewide or regional price agreements.

The source provided contains no recent state or local solicitations for zafirlukast and no geographic activity data. Without posted RFPs, RFQs, ITBs, or IFBs naming this specific pharmaceutical, the code shows no actionable procurement signals at this time. Opportunities under narrower pharmacy or pharmaceutical-supply codes may embed zafirlukast procurement within broader drug-purchasing agreements, but this Commodity code itself carries no current visibility into state or local buying activity.